Lineage Cell Therapeutics (LCTX) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Lineage Cell Therapeutics (LCTX) Tops Q2 EPS by 1c

Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs

August 12, 2021 4:05 PM EDT

OpRegen® Continued to Demonstrate Functional and Anatomical Improvements in Patients with Dry AMD Three Cases of Retinal Tissue Restoration Reported; Longest of Which Has Lasted 3 Years Company Added to Russell 3000® and Russell Microcap® Indexes License Agreement Announced with Immunomic Therapeutics Inc. to Develop New DC-Based Therapeutic New Chief Financial Officer Appointed Cash and Marketable Securities of $68.7M Expected to Support Operations Well Into 2023

CARLSBAD, Calif.--(BUSINESS... More